Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
Medicine
|
October 29, 2011
Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases
Roberto Pérez-Alvarez, Cándido Díaz-Lagares, Francisco García-Hernández, et al.
Seminars in Arthritis and Rheumatism
|
August 17, 2015
Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies
Pilar Brito-Zerón, Xavier Bosch, Marta Pérez-de-Lis, et al.
Clinical and Experimental Rheumatology
|
January 5, 2026
Coexistence of sarcoidosis and spondyloarthritis: a rare but intriguing association
Alessia Alunno, Francesco Carubbi, Begoña De Escalante, et al.
Clinical and Experimental Rheumatology
|
October 2, 2012
Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndrome
Pilar Brito-Zerón, Miriam Akasbi, Xavier Bosch, et al.
Clinical and Experimental Rheumatology
|
June 19, 2012
Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome
Soledad Retamozo, Miriam Akasbi, Pilar Brito-Zerón, et al.
Oral Health and Dental Management
|
July 3, 2014
Factors influencing dry mouth in patients with primary Sjögren syndrome: usefulness of the ESSPRI index
Myriam Gandía, Enma Marianela Morales-Espinoza, Rosa Ma Martín-González, et al.
The Journal of Rheumatology
|
November 3, 2014
Etiopathogenic role of surfactant protein d in the clinical and immunological expression of primary Sjögren syndrome
María José Soto-Cárdenas, Myriam Gandía, Pilar Brito-Zerón, et al.
RMD Open
|
November 22, 2019
Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren's syndrome
Pilar Brito-Zerón, Soledad Retamozo, Belchin Kostov, et al.
Clinical and Experimental Rheumatology
|
October 7, 2020
Autoimmune congenital heart block and primary Sjögren's syndrome: characterisation and outcomes of 49 cases
Pilar Brito-Zerón, Sandra G Pasoto, Angel Robles-Marhuenda, et al.
Scientific Reports
|
March 12, 2026
Rheumatic immune-related adverse effects of immune checkpoint treatment: a retrospective multicentre study
Arturo Llobell-Uriel, Íñigo González-Mazón, Jordi Gratacós, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
Medicine
|
October 29, 2011
Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases
Roberto Pérez-Alvarez, Cándido Díaz-Lagares, Francisco García-Hernández, et al.
Seminars in Arthritis and Rheumatism
|
August 17, 2015
Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies
Pilar Brito-Zerón, Xavier Bosch, Marta Pérez-de-Lis, et al.
Clinical and Experimental Rheumatology
|
January 5, 2026
Coexistence of sarcoidosis and spondyloarthritis: a rare but intriguing association
Alessia Alunno, Francesco Carubbi, Begoña De Escalante, et al.
Clinical and Experimental Rheumatology
|
October 2, 2012
Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndrome
Pilar Brito-Zerón, Miriam Akasbi, Xavier Bosch, et al.
Clinical and Experimental Rheumatology
|
June 19, 2012
Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome
Soledad Retamozo, Miriam Akasbi, Pilar Brito-Zerón, et al.
Oral Health and Dental Management
|
July 3, 2014
Factors influencing dry mouth in patients with primary Sjögren syndrome: usefulness of the ESSPRI index
Myriam Gandía, Enma Marianela Morales-Espinoza, Rosa Ma Martín-González, et al.
The Journal of Rheumatology
|
November 3, 2014
Etiopathogenic role of surfactant protein d in the clinical and immunological expression of primary Sjögren syndrome
María José Soto-Cárdenas, Myriam Gandía, Pilar Brito-Zerón, et al.
RMD Open
|
November 22, 2019
Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren's syndrome
Pilar Brito-Zerón, Soledad Retamozo, Belchin Kostov, et al.
Clinical and Experimental Rheumatology
|
October 7, 2020
Autoimmune congenital heart block and primary Sjögren's syndrome: characterisation and outcomes of 49 cases
Pilar Brito-Zerón, Sandra G Pasoto, Angel Robles-Marhuenda, et al.
Scientific Reports
|
March 12, 2026
Rheumatic immune-related adverse effects of immune checkpoint treatment: a retrospective multicentre study
Arturo Llobell-Uriel, Íñigo González-Mazón, Jordi Gratacós, et al.
Page
of 7